MCAPS Stock Overview
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
MedCap AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr272.00 |
| 52 Week High | kr272.00 |
| 52 Week Low | kr192.60 |
| Beta | 0.64 |
| 1 Month Change | 0% |
| 3 Month Change | 2.06% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 66.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| MCAPS | GB Life Sciences | GB Market | |
|---|---|---|---|
| 7D | 0% | 13.5% | 2.7% |
| 1Y | n/a | -40.1% | 5.2% |
Return vs Industry: Insufficient data to determine how MCAPS performed against the UK Life Sciences industry.
Return vs Market: Insufficient data to determine how MCAPS performed against the UK Market.
Price Volatility
| MCAPS volatility | |
|---|---|
| MCAPS Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 8.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: MCAPS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MCAPS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 478 | Anders Dahlberg | www.medcap.se |
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe.
MedCap AB (publ) Fundamentals Summary
| MCAPS fundamental statistics | |
|---|---|
| Market cap | kr3.71b |
| Earnings (TTM) | kr122.80m |
| Revenue (TTM) | kr1.24b |
30.2x
P/E Ratio3.0x
P/S RatioIs MCAPS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MCAPS income statement (TTM) | |
|---|---|
| Revenue | kr1.24b |
| Cost of Revenue | kr518.00m |
| Gross Profit | kr723.40m |
| Other Expenses | kr600.60m |
| Earnings | kr122.80m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Jul 28, 2023
| Earnings per share (EPS) | 8.29 |
| Gross Margin | 58.27% |
| Net Profit Margin | 9.89% |
| Debt/Equity Ratio | 16.7% |
How did MCAPS perform over the long term?
See historical performance and comparison